Table 4 |
||||
|
Adverse events after baseline but before recurrence of parasitaemia occurring in > 5% of patients, by body weight group |
||||
| Adverse Events |
n (%) |
|||
|
|
||||
| BWG1 5-<10 kg (N = 50) |
BWG2 10-<15 kg (N = 37) |
BWG3 15-<25 kg (N = 16) |
Ttotal 5-<25 kg (N = 103) |
|
|
|
||||
| Anaemia |
32 (64.0) |
20 (54.1) |
7 (43.8) |
59 (57.3) |
| Cough |
20 (40.0) |
11 (29.7) |
2 (12.5) |
33 (32.0) |
| Hepatomegaly |
9 (18.0) |
12 (32.4) |
5 (31.3) |
26 (25.2) |
| Respiratory tract infection |
21 (42.0) |
9 (24.3) |
1 (6.3) |
31 (30.1) |
| Splenomegaly |
10 (20.0) |
9 (24.3) |
2 (12.5) |
21 (20.4) |
| Diarrhoea |
11 (22.0) |
7 (18.9) |
2 (12.5) |
20 (19.4) |
| Vomiting |
10 (20.0) |
3 (8.1) |
5 (31.3) |
18 (17.5) |
| Rashes |
11 (22.0) |
5 (13.5) |
1 (6.3) |
17 (16.5) |
| Anorexia |
9 (18.0) |
5 (13.5) |
1 (6.3) |
15 (14.6) |
| Clonus |
7 (14.0) |
5 (13.5) |
1 (6.3) |
13 (12.6) |
| Insomnia |
7 (14.0) |
3 (8.1) |
1 (6.3) |
11 (10.7) |
| Catarrh |
4 (8.0) |
5 (13.5) |
0 (0.0) |
9 (8.7) |
| Hypothermia |
5 (10.0) |
1 (2.7) |
0 (0.0) |
6 (5.8) |
| Hyperreflexia |
3 (6.0) |
2 (5.4) |
1 (6.3) |
6 (5.8) |
|
|
||||
|
Falade et al. Malaria Journal 2008 7:246 doi:10.1186/1475-2875-7-246 |
||||
